Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients

INTRODUCTION: Reactivation of hepatitis B virus (HBV) infection in patients with past infection has been described in 5% to 10% of individuals undergoing immunosuppressive therapies. No data are available to date on the outcome of patients treated by tumour necrosis factor-alpha (TNFα) inhibitors fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Charpin, Caroline, Guis, Sandrine, Colson, Philippe, Borentain, Patrick, Mattéi, Jean-Pierre, Alcaraz, Patrice, Balandraud, Nathalie, Thomachot, Benoit, Roudier, Jean, Gérolami, René
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003507/
https://www.ncbi.nlm.nih.gov/pubmed/19941642
http://dx.doi.org/10.1186/ar2868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003507/
https://www.ncbi.nlm.nih.gov/pubmed/19941642
http://dx.doi.org/10.1186/ar2868

Ejemplares similares